世界の次世代シーケンシング（NGS）市場：製品別（NOVASEQ、NEXTSEQ、SEQUEL、NANOPORE）、消耗品別、バイオインフォマティクス別、サービス別（EXOME、RNA、DENOVO）、技術別（ION、SMRT）、 用途別（診断、がん）、エンドユーザー別、地域別...市場調査レポートについてご紹介

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 24)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Application-Based Market Estimation
2.3 Market Breakdown & Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 33)
4 Premium Insights (Page No. – 38)
4.1 Next-Generation Sequencing Market Overview
4.2 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)
4.3 Next-Generation Sequencing Market Share, By Technology, 2019 vs 2025
4.4 Next-Generation Sequencing Market, By Application, 2019 vs 2025 (USD Million)
4.5 Next-Generation Sequencing Market, By End User, 2019 vs 2025 (USD Million)
4.6 Next-Generation Sequencing Market: Geographical Snapshot
5 Market Overview (Page No. – 42)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advancements in NGS Platforms
5.2.1.1.1 ISEQ
5.2.1.1.2 ION Genestudio S5
5.2.1.2 Declining Costs
5.2.1.3 Improving Regulatory and Reimbursement Scenario for NGS-Based Diagnostic Tests
5.2.2 Restraints
5.2.2.1 End-User Budget Constraints in Developing Nations
5.2.3 Opportunities
5.2.3.1 Government & Private Support for Large-Scale Sequencing
5.2.3.2 Application of NGS in Precision Medicine and Molecular Diagnostics
5.2.3.3 NGS Data Analysis Using Big Data
5.2.4 Challenges
5.2.4.1 Interpretation of Complex Data From NGS Platforms
5.2.4.2 Ethical Issues
5.2.5 Industry Trends
5.2.5.1 Development of Portable Sequencing Technologies
5.2.5.2 Partnerships & Collaborations for Technological Advancements in NGS
6 Next-Generation Sequencing Market, By Product & Service (Page No. – 50)
6.1 Introduction
6.2 Presequencing Products & Services/Sample Preparation
6.2.1 Increasing Automation in Sample Preparation to Drive Market Growth
6.2.1.1 Library Preparation & Target Enrichment
6.2.1.2 Quality Control
6.3 NGS Consumables
6.3.1 Growing Number of Sequencing Procedures to Propel the Demand for NGS Consumables
6.4 NGS Platforms
6.4.1 Significant Transformation Experienced in the Market Due to Entry of New NGS Platform Providers
6.4.2 Illumina
6.4.2.1 Hiseq Systems
6.4.2.2 Hiseq X Ten & Hiseq X Five Systems
6.4.2.3 Miseq Systems
6.4.2.4 Nextseq Systems
6.4.2.5 Miniseq Systems
6.4.2.6 Novaseq Systems
6.4.2.7 ISEQ 100 Systems
6.4.3 Thermo Fisher Scientific
6.4.3.1 ION PGM Systems
6.4.3.2 ION Proton
6.4.3.3 ION Genestudio S5
6.4.4 Oxford Nanopore Technologies
6.4.5 Pacific Biosciences
6.4.5.1 Pacbio RS Ii
6.4.5.2 Sequel Systems
6.4.6 Other NGS Platforms
6.5 Services for NGS Platforms
6.5.1 Increasing Installation of NGS Platforms to Support Market Growth
6.6 Sequencing Services
6.6.1 Exome & Targeted Resequencing and Custom Panels
6.6.1.1 Development of Technologically Advanced NGS Products & Services to Propel Market Growth
6.6.2 Rna-Seq
6.6.2.1 Launch of Advanced Rna Products & Services to Drive Market Growth
6.6.3 Whole-Genome Sequencing & De Novo Sequencing
6.6.3.1 Reducing Whole-Genome Sequencing Costs to Propel the Growth of This Segment
6.6.4 Other Sequencing Services
6.7 Bioinformatics
6.7.1 NGS Data Analysis Software & Workbenches
6.7.1.1 Development of Advanced Bioinformatics Solutions to Drive Growth in This Segment
6.7.2 NGS Data Analysis Services
6.7.2.1 Availability of Data Analysis Services is the Major Factor Supporting the Growth of This Market.
6.7.3 NGS Storage, Management, and Cloud Computing Solutions
6.7.3.1 Launch of Cloud-Based Solutions to Drive the Market
7 Next-Generation Sequencing Market, By Technology (Page No. – 77)
7.1 Introduction
7.2 Sequencing By Synthesis
7.2.1 Sbs Technology Enables the Highest Production of Base Pairs in A Short Period of Time
7.3 ION Semiconductor Sequencing
7.3.1 ION Semiconductor Sequencing Platforms Possess High-Throughput Capabilities
7.4 Single-Molecule Real-Time Sequencing
7.4.1 Smrt Sequencing Produces Results in A Short Time and at Lower Costs
7.5 Nanopore Sequencing
7.5.1 Nanopore Sequencing is the Only Sequencing Technology With Direct Rna Sequencing Capabilities
7.6 Other Sequencing Technologies
8 Next-Generation Sequencing Market, By Application (Page No. – 84)
8.1 Introduction
8.2 Diagnostics
8.2.1 Cancer Diagnostics
8.2.1.1 Growing Number of New Cancer Cases to Propel Market Growth
8.2.2 Infectious Disease Diagnostics
8.2.2.1 Lack of Awareness About NGS-Based Diagnosis for Infectious Diseases to Hamper Market Growth
8.2.3 Reproductive Health Diagnostics
8.2.3.1 Increasing Awareness About the Benefits of Nipt to Propel Market Growth
8.2.4 Other Diagnostic Applications
8.3 Drug Discovery
8.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery to Support Market Growth
8.4 Agricultural & Animal Research
8.4.1 Growing Funding & Support for Animal & Plant Genomics Research to Drive Market Growth
8.5 Other Applications
9 Next-Generation Sequencing Market, By End User (Page No. – 95)
9.1 Introduction
9.2 Academic Institutes & Research Centers
9.2.1 Development of Cost-Effective NGS Products & Services for Researchers to Propel Market Growth
9.3 Pharmaceutical & Biotechnology Companies
9.3.1 Growing Agreements & Collaborations Between Next-Generation Sequencing Market Players and Pharma Biotech Firms to Fuel Market Growth
9.4 Hospitals & Clinics
9.4.1 Development of Advanced NGS-Based Diagnostic Solutions to Enhance the Adoption of NGS in Hospitals & Clinics
9.5 Other End Users
10 Next-Generation Sequencing Market, By Region (Page No. – 101)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Growing R&D Activities in the US to Drive Market Growth
10.2.2 Canada
10.2.2.1 Increasing Government Initiatives in Genomics Research Will Boost the Adoption of NGS
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Dominates the European Next-Generation Sequencing Market
10.3.2 France
10.3.2.1 Government Initiatives to Support Genomics Research—A Major Factor Driving Market Growth in France
10.3.3 UK
10.3.3.1 Favorable Funding Scenario for Genomics Research in the Country to Support the Adoption of NGS
10.3.4 Spain
10.3.4.1 Increasing Number of Conferences Focusing on NGS to Support Market Growth in Spain
10.3.5 Italy
10.3.5.1 Favorable Funding Scenario to Drive the Next-Generation Sequencing Market in Italy
10.3.6 Netherlands
10.3.6.1 Increasing Focus of Market Players on Developing NGS Technologies to Support Market Growth
10.3.7 RoE
10.4 Asia Pacific
10.4.1 China
10.4.1.1 China to Register the Highest Growth in the APAC Next-Generation Sequencing Market
10.4.2 Japan
10.4.2.1 High Incidence of Genetic Disorders in the Country has Resulted in the Increased Adoption of NGS
10.4.3 Australia
10.4.3.1 Increasing Public and Private Initiatives to Support the Adoption of NGS Technologies in Australia
10.4.4 India
10.4.4.1 Growing Prevalence of Target Diseases in India to Support Market Growth
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.1.1 High Prevalence of HIV in Brazil to Drive the Demand for NGS
10.5.2 Mexico
10.5.2.1 Economic Growth in Mexico to Support the Growth of the Next-Generation Sequencing Market
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Lack of Infrastructure for Genomics Research to Hamper the Growth of the Next-Generation Sequencing Market in the Mea
11 Competitive Landscape (Page No. – 144)
11.1 Introduction
11.2 Competitive Leadership Mapping (Overall Market)
11.2.1 Terminology/Nomenclature
11.2.1.1 Visionary Leaders
11.2.1.2 Innovators
11.2.1.3 Dynamic Differentiators
11.2.1.4 Emerging Companies
11.3 Competitive Scenario (2016–2019)
11.4 Next-Generation Sequencing Market Ranking: Top Three Market Players (2018)
12 Company Profiles (Page No. – 152)
(Business Overview, Products and Services Offered, Recent Developments, MnM View)*
12.1 Illumina, Inc.
12.2 Thermo Fisher Scientific, Inc.
12.3 BGI Group
12.4 Perkinelmer
12.5 Agilent Technologies, Inc.
12.6 Qiagen N.V.
12.7 F. Hoffmann-La Roche AG
12.8 Genewiz (A Part of Brooks Automation)
12.9 Eurofins Scientific
12.10 Psomagen, Inc. (Formerly Known as Macrogen)
12.11 Oxford Nanopore Technologies
12.12 10x Genomics
12.13 Takara Bio
12.14 Zymo Research
12.15 Nugen Technologies (A Part of Tecan Trading AG)
12.16 Other Companies
12.16.1 Hamilton Company
12.16.2 Beckman Coulter (A Subsidiary of Danaher)
12.16.3 Becton, Dickinson and Company
12.16.4 Genotypic Technology
12.16.5 Lucigen Corporation
*Business Overview, Products and Services Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 218)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details